Table of Contents Author Guidelines Submit a Manuscript
BioMed Research International
Volume 2014, Article ID 485723, 6 pages
http://dx.doi.org/10.1155/2014/485723
Research Article

Iron Metabolism Disturbance in a French Cohort of ALS Patients

1Unité Mixte de Recherche U930, Institut National de la Santé et de la Recherche Médicale, Université François-Rabelais, Equipe “Neurogénétique et Neurométabolomique”, 10 boulevard Tonnellé, 37032 Tours, France
2Laboratoire de Biochimie et de Biologie Moléculaire, Hôpital Bretonneau, Centre Hospitalier Régional Universitaire de Tours, 37044 Tours, France
3Centre SLA, Service de Neurologie, Centre Hospitalier Régional Universitaire de Tours, 37044 Tours, France
4Service de Neurologie, Centre Hospitalier Régional Universitaire de Lille, 59037 Lille, France
5Laboratoire de Biochimie, Hôpital Trousseau, Centre Hospitalier Régional Universitaire de Tours, 37044 Tours, France
6Service de Médecine Interne, Centre Hospitalier Régional Universitaire de Tours, 37044 Tours, France

Received 14 April 2014; Revised 16 June 2014; Accepted 18 June 2014; Published 2 July 2014

Academic Editor: Aaron S. Dumont

Copyright © 2014 Charlotte Veyrat-Durebex et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. M. van Blitterswijk, M. A. van Es, E. A. M. Hennekam et al., “Evidence for an oligogenic basis of amyotrophic lateral sclerosis,” Human Molecular Genetics, vol. 21, no. 17, pp. 3776–3784, 2012. View at Publisher · View at Google Scholar · View at Scopus
  2. P. J. Shaw, “Molecular and cellular pathways of neurodegeneration in motor neurone disease,” Journal of Neurology, Neurosurgery and Psychiatry, vol. 76, no. 8, pp. 1046–1057, 2005. View at Publisher · View at Google Scholar · View at Scopus
  3. P. Jenner, “Clues to the mechanism underlying dopamine cell death in Parkinson's disease,” Journal of Neurology Neurosurgery and Psychiatry, vol. 52, pp. 22–28, 1989. View at Publisher · View at Google Scholar · View at Scopus
  4. A. I. Bush, “The metal theory of Alzheimer's disease,” Journal of Alzheimer's Disease, vol. 33, supplement 1, pp. S277–S281, 2013. View at Publisher · View at Google Scholar · View at Scopus
  5. H. Oba, T. Araki, K. Ohtomo et al., “Amyotrophic lateral sclerosis: T2 shortening in motor cortex at MR imaging,” Radiology, vol. 189, no. 3, pp. 843–846, 1993. View at Google Scholar · View at Scopus
  6. E. J. Kasarskis, L. Tandon, M. A. Lovell, and W. D. Ehmann, “Aluminum, calcium, and iron in the spinal cord of patients with sporadic amyotrophic lateral sclerosis using laser microprobe mass spectroscopy: a preliminary study,” Journal of the Neurological Sciences, vol. 130, no. 2, pp. 203–208, 1995. View at Publisher · View at Google Scholar · View at Scopus
  7. A. Ignjatovic, Z. Stevic, S. Lavrnic, M. Dakovic, and G. Bacic, “Brain iron MRI: a biomarker for amyotrophic lateral sclerosis,” Journal of Magnetic Resonance Imaging, vol. 38, no. 6, pp. 1472–1479, 2013. View at Publisher · View at Google Scholar
  8. Y. J. Suh, K. I. Rathore, K. Schulz, P. Ponka, P. Arosio, and S. David, “Dysregulation of iron homeostasis in the CNS contributes to disease progression in a mouse model of amyotrophic lateral sclerosis,” The Journal of Neuroscience, vol. 29, no. 3, pp. 610–619, 2009. View at Publisher · View at Google Scholar · View at Scopus
  9. E. F. Goodall, M. S. Haque, and K. E. Morrison, “Increased serum ferritin levels in amyotrophic lateral sclerosis (ALS) patients,” Journal of Neurology, vol. 255, no. 11, pp. 1652–1656, 2008. View at Publisher · View at Google Scholar · View at Scopus
  10. R. M. Mitchell, Z. Simmons, J. L. Beard, H. E. Stephens, and J. R. Connor, “Plasma biomarkers associated with ALS and their relationship to iron homeostasis,” Muscle and Nerve, vol. 42, no. 1, pp. 95–103, 2010. View at Publisher · View at Google Scholar · View at Scopus
  11. Y. Nadjar, P. Gordon, P. Corcia et al., “Elevated serum ferritin is associated with reduced survival in amyotrophic lateral sclerosis,” PLoS ONE, vol. 7, no. 9, Article ID e45034, 2012. View at Publisher · View at Google Scholar · View at Scopus
  12. K. Ikeda, T. Hirayama, T. Takazawa, K. Kawabe, and Y. Iwasaki, “Relationships between disease progression and serum levels of lipid, urate, creatinine and ferritin in Japanese patients with amyotrophic lateral sclerosis: a cross-sectional study,” Internal Medicine, vol. 51, no. 12, pp. 1501–1508, 2012. View at Publisher · View at Google Scholar · View at Scopus
  13. Y. Mizuno, M. Amari, M. Takatama, H. Aizawa, B. Mihara, and K. Okamoto, “Transferrin localizes in Bunina bodies in amyotrophic lateral sclerosis,” Acta Neuropathologica, vol. 112, no. 5, pp. 597–603, 2006. View at Publisher · View at Google Scholar · View at Scopus
  14. E. F. Goodall, M. J. Greenway, I. Van Marion, C. B. Carroll, O. Hardiman, and K. E. Morrison, “Association of the H63D polymorphism in the hemochromatosis gene with sporadic ALS,” Neurology, vol. 65, no. 6, pp. 934–937, 2005. View at Publisher · View at Google Scholar · View at Scopus
  15. G. Restagno, F. Lombardo, P. Ghiglione et al., “HFE H63D polymorphism is increased in patients with amyotrophic lateral sclerosis of Italian origin,” Journal of Neurology, Neurosurgery and Psychiatry, vol. 78, no. 3, p. 327, 2007. View at Publisher · View at Google Scholar · View at Scopus
  16. N. A. Sutedja, R. J. Sinke, P. W. J. van Vught et al., “The association between H63D mutations in HFE and amyotrophic lateral sclerosis in a Dutch population,” Archives of Neurology, vol. 64, no. 1, pp. 63–67, 2007. View at Publisher · View at Google Scholar · View at Scopus
  17. W. van Rheenen, F. P. Diekstra, P. T. C. van Doormaal et al., “H63D polymorphism in HFE is not associated with amyotrophic lateral sclerosis,” Neurobiology of Aging, vol. 34, no. 5, pp. 1517.e5–1517.e7, 2013. View at Publisher · View at Google Scholar · View at Scopus
  18. H. Blasco, P. Vourc'H, Y. Nadjar et al., “Association between divalent metal transport 1 encoding gene (SLC11A2) and disease duration in amyotrophic lateral sclerosis,” Journal of the Neurological Sciences, vol. 303, no. 1-2, pp. 124–127, 2011. View at Publisher · View at Google Scholar · View at Scopus
  19. B. R. Brooks, R. G. Miller, M. Swash, and T. L. Munsat, “El Escorial revisited: revised criteria for the diagnosis of amyotrophic lateral sclerosis,” Amyotrophic Lateral Sclerosis, vol. 1, no. 5, pp. 293–299, 2000. View at Publisher · View at Google Scholar · View at Scopus
  20. F. Kimura, C. Fujimura, S. Ishida et al., “Progression rate of ALSFRS-R at time of diagnosis predicts survival time in ALS,” Neurology, vol. 66, no. 2, pp. 265–267, 2006. View at Publisher · View at Google Scholar · View at Scopus
  21. J. Praline, H. Blasco, P. Vourc'h et al., “Study of the HFE gene common polymorphisms in French patients with sporadic amyotrophic lateral sclerosis,” Journal of the Neurological Sciences, vol. 317, no. 1-2, pp. 58–61, 2012. View at Publisher · View at Google Scholar · View at Scopus
  22. S. Zoccolella, E. Beghi, G. Palagano et al., “Analysis of survival and prognostic factors in amyotrophic lateral sclerosis: a population based study,” Journal of Neurology, Neurosurgery and Psychiatry, vol. 79, no. 1, pp. 33–37, 2008. View at Publisher · View at Google Scholar · View at Scopus
  23. B. Marin, J. Gil, P. M. Preux, B. Funalot, and P. Couratier, “Incidence of amyotrophic lateral sclerosis in the Limousin region of France, 1997–2007,” Amyotrophic Lateral Sclerosis, vol. 10, no. 4, pp. 216–220, 2009. View at Publisher · View at Google Scholar · View at Scopus
  24. P. H. Gordon, F. Salachas, L. Lacomblez et al., “Predicting survival of patients with amyotrophic lateral sclerosis at presentation: a 15-year experience,” Neurodegenerative Diseases, vol. 12, no. 2, pp. 81–90, 2013. View at Publisher · View at Google Scholar · View at Scopus
  25. L. C. Wijesekera and P. N. Leigh, “Amyotrophic lateral sclerosis,” Orphanet Journal of Rare Diseases, vol. 4, no. 1, article 3, 2009. View at Publisher · View at Google Scholar · View at Scopus
  26. O. Hardiman, “Management of respiratory symptoms in ALS,” Journal of Neurology, vol. 258, no. 3, pp. 359–365, 2011. View at Publisher · View at Google Scholar · View at Scopus
  27. C. Paillisse, L. Lacomblez, M. Dib, G. Bensimon, S. Garcia-Acosta, and V. Meininger, “Prognostic factors for survival in amyotrophic lateral sclerosis patients treated with riluzole,” Amyotrophic Lateral Sclerosis and Other Motor Neuron Disorders, vol. 6, no. 1, pp. 37–44, 2005. View at Publisher · View at Google Scholar · View at Scopus
  28. P. G. Ince, P. J. Shaw, J. M. Candy et al., “Iron, selenium and glutathione peroxidase activity are elevated in sporadic motor neuron disease,” Neuroscience Letters, vol. 182, no. 1, pp. 87–90, 1994. View at Publisher · View at Google Scholar · View at Scopus
  29. J. Y. Kwan, S. Y. Jeong, P. van Gelderen et al., “Iron accumulation in deep cortical layers accounts for MRI signal abnormalities in ALS: correlating 7 tesla MRI and pathology,” PLoS ONE, vol. 7, no. 4, Article ID e35241, 2012. View at Publisher · View at Google Scholar · View at Scopus
  30. S. Oshiro, M. S. Morioka, and M. Kikuchi, “Dysregulation of iron metabolism in Alzheimer's disease, Parkinson's disease, and amyotrophic lateral sclerosis,” Advances in Pharmacological Sciences, vol. 2011, Article ID 378278, 2011. View at Publisher · View at Google Scholar · View at Scopus
  31. A. J. Nappi and E. Vass, “Iron, metalloenzymes and cytotoxic reactions,” Cellular and Molecular Biology, vol. 46, no. 3, pp. 637–647, 2000. View at Google Scholar · View at Scopus
  32. D. B. Kell, “Towards a unifying, systems biology understanding of large-scale cellular death and destruction caused by poorly liganded iron: Parkinson's, Huntington's, Alzheimer's, prions, bactericides, chemical toxicology and others as examples,” Archives of Toxicology, vol. 84, no. 11, pp. 825–889, 2010. View at Publisher · View at Google Scholar · View at Scopus
  33. M. Hadzhieva, E. Kirches, A. Wilisch-Neumann et al., “Dysregulation of iron protein expression in the G93A model of amyotrophic lateral sclerosis,” Neuroscience, vol. 230, pp. 94–101, 2013. View at Publisher · View at Google Scholar · View at Scopus
  34. Q. Wang, X. Zhang, S. Chen et al., “Prevention of motor neuron degeneration by novel iron chelators in SOD1 G93A transgenic mice of amyotrophic lateral sclerosis,” Neurodegenerative Diseases, vol. 8, no. 5, pp. 310–321, 2011. View at Publisher · View at Google Scholar · View at Scopus
  35. S. J. Dixon, K. M. Lemberg, M. R. Lamprecht et al., “Ferroptosis: an iron-dependent form of nonapoptotic cell death,” Cell, vol. 149, no. 5, pp. 1060–1072, 2012. View at Publisher · View at Google Scholar · View at Scopus
  36. I. Pichler, M. F. del Greco, M. Gögele et al., “Serum iron levels and the risk of Parkinson disease: a mendelian randomization study,” PLoS Medicine, vol. 10, no. 6, Article ID e1001462, 2013. View at Publisher · View at Google Scholar · View at Scopus
  37. R. C. McCarthy and D. J. Kosman, “Glial cell ceruloplasmin and hepcidin differentially regulate iron efflux from brain microvascular endothelial cells,” PLoS ONE, vol. 9, no. 2, Article ID e89003, 2014. View at Google Scholar
  38. E. A. Winkler, J. D. Sengillo, A. P. Sagare et al., “Blood-spinal cord barrier disruption contributes to early motor-neuron degeneration in ALS-model mice,” Proceedings of the National Academy of Sciences of the United States of America, vol. 111, no. 11, pp. E1035–E1042, 2014. View at Google Scholar
  39. M. Qureshi, R. H. Brown Jr., J. T. Rogers, and M. E. Cudkowicz, “Serum ferritin and metal levels as risk factors for amyotrophic lateral sclerosis,” Open Neurology Journal, vol. 2, pp. 51–54, 2008. View at Publisher · View at Google Scholar
  40. P. Arosio and S. Levi, “Ferritin, iron homeostasis, and oxidative damage,” Free Radical Biology and Medicine, vol. 33, no. 4, pp. 457–463, 2002. View at Publisher · View at Google Scholar · View at Scopus
  41. C. M. Velásquez Rodríguez, B. Parra Sosa, G. Morales Mira et al., ““Free” iron, transferrin and ferritin levels in serum and their relation with severe malnutrition,” Anales de Pediatria, vol. 66, no. 1, pp. 17–23, 2007. View at Publisher · View at Google Scholar · View at Scopus
  42. L. Piskorz, T. Lesiak, M. Brocki et al., “Biochemical and functional indices of malnutrition in patients with operable, non-microcelullar lung cancer,” Nutricion Hospitalaria, vol. 26, no. 5, pp. 1025–1032, 2011. View at Publisher · View at Google Scholar · View at Scopus
  43. N. Limousin, H. Blasco, P. Corcia et al., “Malnutrition at the time of diagnosis is associated with a shorter disease duration in ALS,” Journal of the Neurological Sciences, vol. 297, no. 1-2, pp. 36–39, 2010. View at Publisher · View at Google Scholar · View at Scopus